Zynex Inc (OTCQB:ZYXI)

Tuesday, August 22, 2017 | Spotlight
ZYXI ($1.21) - Taglich Brothers initiated ZYXI with “Speculative Buy” rating and $2.30 price target....
Monday, August 14, 2017 | Spotlight
Looking to Add to Our ZYXI Long Position Shares of $ZYXI ($0.81) have more than doubled since our original note on June 6,...
Friday, July 14, 2017 | Spotlight
$ZYXI ($0.82) Shares of ZYXI have more than doubled since our original note on June 6, 2017 when shares were trading at $...
See All Research...
 Zynex, Inc. (founded in 1996) engineers, manufactures, markets and sells its own design of electrotherapy medical devices in two distinct markets: standard digital electrotherapy products for pain relief and pain management; and the NeuroMove(TM) for stroke and spinal cord injury (SCI) rehabilitation. Zynex's product lines are fully developed, FDA-cleared, commercially sold, and have been developed to uphold the Company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain.

Web site: http://www.zynexmed.com/

Last updated July 11, 2008